Zylox-Tonbridge Medical Technology Co., Ltd. - Laporan Laba Rugi (TTM)

Zylox-Tonbridge Medical Technology Co., Ltd.
HK ˙ SEHK ˙ CNE100004JD2
HK$ 25.40 ↑0.62 (2.50%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Zylox-Tonbridge Medical Technology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 28 62 97 137 178 219 259 297 334 373 411 470 528 596 664 723 782 840 898
Change (%) 125.54 55.66 41.70 29.43 22.84 18.59 14.45 12.63 11.58 10.38 14.13 12.38 12.87 11.40 8.96 8.22 7.41 6.90
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 11 20 29 38 46 55 64 73 81 93 104 123 143 166 188 205 223 239 256
Change (%) 78.59 44.01 28.89 22.41 19.45 16.28 13.67 12.03 13.64 12.01 18.88 15.88 15.97 13.77 9.08 8.33 7.59 7.05
% of Revenue 41.06 32.51 30.08 27.36 25.87 25.16 24.67 24.50 24.37 24.82 25.19 26.23 27.05 27.79 28.38 28.42 28.45 28.49 28.53
Gross Operating Profit 16 42 68 100 132 164 195 224 253 280 308 346 385 430 475 518 560 601 642
Change (%) 158.24 61.28 47.21 32.07 24.02 19.37 14.71 12.82 10.92 9.84 12.53 11.14 11.72 10.49 8.90 8.18 7.34 6.84
% of Revenue 58.94 67.49 69.92 72.64 74.13 74.84 75.33 75.50 75.63 75.18 74.81 73.77 72.95 72.21 71.62 71.58 71.55 71.51 71.47
SG&A 51 85 119 158 196 207 219 234 249 261 272 275 278 277 276 271 266 275 283
Change (%) 65.97 39.75 32.08 24.29 5.80 5.48 7.07 6.60 4.55 4.35 1.06 1.05 -0.31 -0.31 -1.88 -1.92 3.32 3.21
% of Revenue 186.19 137.01 123.00 114.66 110.10 94.83 84.34 78.90 74.68 69.97 66.15 58.57 52.66 46.51 41.62 37.48 33.97 32.67 31.55
R&D 72 83 94 131 168 191 213 223 233 252 270 266 261 246 232 232 233 243 253
Change (%) 14.93 12.99 39.81 28.47 13.40 11.82 4.76 4.55 7.87 7.30 -1.71 -1.73 -5.61 -5.94 0.32 0.32 4.30 4.12
% of Revenue 260.81 132.91 96.48 95.19 94.48 87.23 82.25 75.28 69.88 67.56 65.67 56.56 49.46 41.36 34.92 32.15 29.81 28.94 28.19
OpEx 125 180 235 316 396 437 479 518 558 599 640 661 683 680 684 708 723 759 795
Change (%) 44.15 30.63 34.16 25.46 10.42 9.44 8.25 7.62 7.35 6.84 3.42 3.31 -0.54 0.70 3.43 2.13 4.96 4.73
% of Revenue 452.29 289.07 242.57 229.66 222.63 200.12 184.67 174.66 166.90 160.57 155.42 140.84 129.47 114.09 103.13 97.90 92.40 90.29 88.45
Operating Income -97 -118 -138 -178 -218 -219 -219 -221 -224 -226 -228 -192 -156 -84 -21 15 60 82 104
Change (%) 21.04 17.38 28.87 22.40 0.29 0.29 0.93 0.92 1.02 1.01 -15.90 -18.90 -46.03 -75.28 -173.13 292.06 37.18 27.10
% of Revenue -352.29 -189.07 -142.57 -129.66 -122.63 -100.12 -84.67 -74.66 -66.90 -60.57 -55.42 -40.84 -29.47 -14.09 -3.13 2.10 7.60 9.71 11.55
Interest Expense -1 -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -0 -2 -2 -1
Change (%) -26.35 -35.78 -1.27 -1.29 55.21 35.57 5.88 5.56 -5.96 -6.33 -22.80 25.78 -59.01
% of Revenue -2.41 -0.79 -0.32 -0.23 -0.17 -0.22 -0.25 -0.23 -0.22 -0.18 -0.15 -0.10 -0.28 -0.32 -0.12
Net Income -100 -118 -135 -168 -200 -178 -155 -135 -114 -119 -124 -101 -79 -27 26 63 100 126 153
Change (%) 17.38 14.80 23.75 19.19 -11.07 -12.45 -13.48 -15.58 4.41 4.22 -18.14 -22.16 -66.29 -196.61 145.47 59.26 26.10 20.70
% of Revenue -363.61 -189.23 -139.56 -121.88 -112.24 -81.26 -59.99 -45.35 -33.99 -31.80 -30.03 -21.54 -14.92 -4.46 3.86 8.71 12.81 15.04 16.98

Source: Capital IQ

Other Listings
DE:818 € 2.72
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista